Fil Randazzo, deputy director, Discovery and Translational Sciences, develops strategies and oversees a portfolio of investments and partnerships focused on health impact. He works with partners and entrepreneurs all over the world to help find new solutions to difficult problems.
Fil developed and leads the Vaccine Discovery Partnership (VxDP) program which manages direct R&D partnerships with the vaccine pharma companies. He serves on the foundation’s team for program-related equity investments and as the foundation’s relationship manager with the Global Good Fund at Intellectual Ventures, LLC.
Joining the foundation in 2005, Fil co-launched and co-managed the foundation’s flagship technology and innovation engine, Grand Challenges in Global Health (GCGH). He continues to manage a number of high-risk investments. Prior to that, Fil initiated and managed the foundation’s first programs in agriculture and agricultural biotechnology, with one program recently included in Time magazine’s 25 Best Inventions of 2014. He is also a founding member of the foundation’s Agricultural Development team.
Fil has trained as an American Cancer Society postdoctoral fellow at Stanford University and at Mount Sinai Hospital Toronto, earned a Ph.D. in Molecular, Cellular and Developmental Biology from Indiana University in 1991, and a B.S. from the University of Notre Dame in 1985 where he majored in microbiology and anthropology. Prior to joining the foundation, Fil spent ten years at the Chiron Corporation. He holds ten patents.